Safety and Immunogenicity of the RSV D46cpΔM2-2 Vaccine in RSV-Seropositive Children and RSV-Seronegative Infants and Children
Clinical trial NCT02601612 · COMPLETED
Trial details
- NCT number
- NCT02601612
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-01
- Primary completion
- 2018-04-26
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.